Roswell Park received more than $21.8 million in recent competitive grants and contracts to launch new investigations or continue major research efforts. This includes funding from NCI’s Cancer Moonshot program as well as renewals for high-impact projects based at Roswell Park.
As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.
